Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 23
2003 15
2004 9
2005 8
2006 2
2007 2
2008 3
2009 3
2010 4
2011 1
2012 7
2013 4
2014 4
2015 8
2016 5
2017 11
2018 6
2019 5
2020 12
2021 22
2022 56
2023 46
2024 58
2025 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus.
Suzuki Y, Kaneko H, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Kamiya K, Matsunaga A, Ako J, Node K, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: okada a. Cardiovasc Diabetol. 2022 May 18;21(1):67. doi: 10.1186/s12933-022-01508-6. Cardiovasc Diabetol. 2022. PMID: 35585590 Free PMC article.
Author's reply.
Isogai T, Morita K, Okada A, Yasunaga H. Isogai T, et al. Among authors: okada a. J Cardiol. 2025 May 1:S0914-5087(25)00110-8. doi: 10.1016/j.jjcc.2025.04.011. Online ahead of print. J Cardiol. 2025. PMID: 40316166 No abstract available.
Association of Inflammatory Bowel Disease with Incident IgA Nephropathy.
Nakayama T, Kaneko H, Okada A, Suzuki Y, Fujiu K, Takeda N, Morita H, Takeda N, Fukui A, Yokoo T, Yasunaga H, Nangaku M, Hayashi K. Nakayama T, et al. Among authors: okada a. Clin J Am Soc Nephrol. 2024 Jun 1;19(6):704-711. doi: 10.2215/CJN.0000000000000457. Epub 2024 Apr 11. Clin J Am Soc Nephrol. 2024. PMID: 38600627
Association of SGLT2 inhibitors with incident cancer.
Suzuki Y, Kaneko H, Okada A, Ko T, Jimba T, Fujiu K, Takeda N, Morita H, Komuro J, Ieda M, Node K, Komuro I, Yasunaga H, Takeda N. Suzuki Y, et al. Among authors: okada a. Diabetes Metab. 2024 Nov;50(6):101585. doi: 10.1016/j.diabet.2024.101585. Epub 2024 Oct 24. Diabetes Metab. 2024. PMID: 39455021
Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome-Wide Association and Mendelian Randomization Study.
Inoue K, Naito T, Fuji R, Sonehara K, Yamamoto K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Ohno H; BioBank Japan; Morisaki T, Hattori N, Goto A, Nishikawa T, Oki K, Okada Y. Inoue K, et al. Among authors: okada a. J Am Heart Assoc. 2024 Aug 6;13(15):e034180. doi: 10.1161/JAHA.123.034180. Epub 2024 Aug 5. J Am Heart Assoc. 2024. PMID: 39101507 Free PMC article.
296 results